Cell-Based Immunotherapy Therapy Solutions
With the recent surge of T cell–based immunotherapies, more researchers are taking interest in these specialized immune cells, particularly with respect to the development of chimeric antigen receptor T cell (CAR-T) therapies. Whether you’re developing a CAR-T therapy, another type of T cell immunotherapy, or working with other immune cell types, we can help you move from research to the clinic and beyond. Our cell culture med…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
With the recent surge of T cell–based immunotherapies, more researchers are taking interest in these specialized immune cells, particularly with respect to the development of chimeric antigen receptor T cell (CAR-T) therapies. Whether you’re developing a CAR-T therapy, another type of T cell immunotherapy, or working with other immune cell types, we can help you move from research to the clinic and beyond. Our cell culture media and reagents help minimize the risk of contamination and variability and provide extensive traceability documentation including FDA Drug Master Files and Regulatory Support Files to support regulatory review, helping to facilitate a seamless transition from research to commercialization. Our goal is to help you reduce the amount of time from initial discovery to approved therapy.
